Genetic testing offers real insights into how patients should be treated, but insurers have been reluctant to cover the cost of the tests. With a wave of new, more targeted biologics in the pipeline along with new tests to identify the people most likely to benefit from them, look for the issue to heat up considerably in the next few years.
- read the report on genetic testing from the San Jose Mercury News